company background image
OKYO logo

OKYO Pharma LSE:OKYO Lagerbericht

Letzter Preis

UK£0.91

Marktkapitalisierung

UK£23.2m

7D

-31.7%

1Y

-63.6%

Aktualisiert

22 May, 2023

Daten

Finanzdaten des Unternehmens +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

OKYO Aktienübersicht

A clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.

OKYO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

OKYO Pharma Limited Wettbewerber

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for OKYO Pharma
Historical stock prices
Current Share PriceUK£0.91
52 Week HighUK£3.90
52 Week LowUK£0.88
Beta-0.062
1 Month Change-9.68%
3 Month Change-65.69%
1 Year Change-63.64%
3 Year Change-45.10%
5 Year Changen/a
Change since IPO-98.13%

Aktuelle Nachrichten und Updates

Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Nov 26
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Recent updates

Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Nov 26
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?

Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?

Jan 27
Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation

Sep 22
Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation

We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth

Mar 17
We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth

We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow

Dec 02
We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow

Aktionärsrenditen

OKYOGB BiotechsGB Markt
7D-31.7%-0.7%-0.6%
1Y-63.6%-21.8%6.3%

Rendite im Vergleich zur Industrie: OKYO underperformed the UK Biotechs industry which returned -16.5% over the past year.

Rendite vs. Markt: OKYO underperformed the UK Market which returned -2.2% over the past year.

Preisvolatilität

Is OKYO's price volatile compared to industry and market?
OKYO volatility
OKYO Average Weekly Movement18.1%
Biotechs Industry Average Movement6.6%
Market Average Movement4.9%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.7%

Stabiler Aktienkurs: OKYO's share price has been volatile over the past 3 months.

Volatilität im Zeitverlauf: OKYO's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of UK stocks.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
20077Gary Jacobwww.okyopharma.com

OKYO Pharma Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von OKYO Pharma im Vergleich zum Marktanteil des Unternehmens?
OKYO grundlegende Statistiken
MarktanteilUK£23.22m
Gewinn(TTM)-UK£6.70m
Umsatz(TTM)n/a

0.0x

Kurs-Umsatz-Verhältnis

-3.5x

Kurs-Gewinn-Verhältnis

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
OKYO Gewinn- und Verlustrechnung (TTM)
EinnahmenUK£0
Kosten der EinnahmenUK£4.39m
Bruttogewinn-UK£4.39m
Sonstige AusgabenUK£2.31m
Umsatz-UK£6.70m

Zuletzt gemeldete Gewinne

Sep 30, 2022

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)-0.26
Bruttomarge0.00%
Nettogewinnspanne0.00%
Schulden/Eigenkapital-Verhältnis0%

Wie hat sich OKYO auf lange Sicht entwickelt?

Historische Performance und Vergleiche